Sumitomo Pharma valuation

4506 · TSE · JPY

Compare Sumitomo Pharma
¥2,018.00Change from previous close: −0.49%Absolute change: −¥10.00

Close · November 16, 2026

Valuation

The P/E ratio is 19.2. The average price target of 7 analysts is ¥2,242.86.

Data as of November 15, 2026

Sumitomo Pharma compared with similar companies

Sumitomo Pharma's P/E (trailing 12 months): 19.2, −32% against the median of a group of 11 similar companies (28.4).

Sumitomo Pharma's metrics compared with similar companies
MetricSumitomo PharmaMedian25th–75th percentileBand
P/E (trailing 12 months)19.228.417.7 – 50.8Middle
Forward P/E118.424.017.8 – 41.4High
EV/EBITDA58.318.415.7 – 43.0High
Price/book2.112.451.87 – 6.96Middle
Price/sales1.853.912.42 – 7.22Low
Gross margin53.3%72.2%56.8% – 76.3%Low
Operating margin-0.4%18.6%12.1% – 23.2%Low
Net margin9.4%13.8%11.3% – 23.3%Low
ROE13.3%14.7%11.4% – 18.5%Middle
Debt/equity0.320.280.03 – 0.41Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Sumitomo Pharma: valuation over time

On the latest fiscal year's earnings (2026), Sumitomo Pharma's P/E today is 7.50, below the median of its last 8 fiscal years (13.4; between 7.72 and 25.2 from 2017 to 2026). Relative to earnings, the stock costs less than it used to.

Sumitomo Pharma P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
Mar 2026¥2,075.50¥268.997.72——
Mar 2025¥729.00¥59.4912.3——
Mar 2024¥404.00-¥792.79———
Mar 2023¥810.00-¥187.55—¥21.002.6%
Mar 2022¥1,208.00¥141.998.51¥28.002.3%
Mar 2021¥1,927.00¥141.5013.6¥28.001.5%
Mar 2020¥1,403.00¥102.5813.7¥28.002.0%
Mar 2019¥2,737.00¥122.3922.4¥26.000.9%
Mar 2018¥1,786.00¥134.5313.3¥18.001.0%
Mar 2017¥1,838.00¥72.9725.2¥18.001.0%

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
¥909.75B
Enterprise value
¥971.68B
PEG
1.93
EV/revenue
1.97

Profitability and growth

ROA
-0.1%
ROIC
-0.2%
Revenue growth (year over year)
15.0%
Earnings growth (year over year)
-78.5%

Financial health

Total cash
¥77.76B
Total debt
¥139.69B
Current ratio
1.36
Quick ratio
0.93
Altman Z-Score
2.15
Piotroski F-Score
5.00

Dividends

Payout ratio
0.0%

Analysts and estimates

Average price target
¥2,242.86
Median price target
¥2,500.00
High price target
¥2,800.00
Low price target
¥1,500.00
Analysts with a price target
7
Consensus
Buy
Forward EPS
¥17.13
EPS estimate, current year
¥191.95

Shares and trading

Beta
0.48
Average volume
4M
Shares outstanding
448.59M
Float
238.43M
Institutional ownership
23.2%
Insider ownership
48.6%